Progress of experimental researches on Chinese herbal compounds for inducing tumor cell apoptosis

Fu-peng Jin1, Mei Zhang

  • 1Department of Chinese Medicine, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, China.

Insights

Chinese herbal compounds (CHC) show promise in cancer treatment by inducing cell apoptosis. This review covers CHC

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Cell apoptosis, a regulated cell death process, is a key target for novel cancer therapies.
  • Chinese herbal compounds (CHC) are increasingly investigated for their therapeutic potential in oncology.

Purpose of the Study:

  • To review experimental studies on the efficacy of Chinese herbal compounds (CHC) in inducing tumor cell apoptosis.
  • To explore the mechanisms through which CHC induce apoptosis, including gene expression, morphology, and immune response.
  • To examine the effects of disassembled CHC and their synergistic interactions with chemotherapy.

Main Methods:

  • Literature review of experimental studies on CHC and tumor cell apoptosis.
  • Analysis of mechanisms including gene expression regulation, cell morphology changes, and telomerase activity.
  • Evaluation of immune enhancement effects and synergistic effects with chemotherapy.

Main Results:

  • Experimental studies demonstrate that CHC can effectively induce tumor cell apoptosis through various molecular pathways.
  • Specific CHC components and their combined use with chemotherapy exhibit significant synergistic effects in apoptosis induction.
  • CHC influence gene expression, alter cell morphology, modulate telomerase activity, and enhance immune responses against tumors.

Conclusions:

  • Chinese herbal compounds represent a promising avenue for cancer treatment by inducing apoptosis.
  • Understanding the mechanisms of CHC action, including synergistic effects, is crucial for developing effective cancer therapies.
  • Further research into CHC is warranted to optimize their use in clinical oncology.